Breo
Last updated October 9, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Breo (倍轻松) is a Chinese consumer brand in the personal-care appliance space, associated in particular with eye massagers and similar wellness devices. The brand is positioned in the consumer discretionary / consumer durables segment, specifically within personal-care appliances and vision-care devices. The supplied evidence for this dossier is limited: the official website domain mybreo.com currently hosts content for BREO ELLIPTA, a prescription asthma and COPD medicine from GSK, which is a different commercial entity that shares the "Breo" name. Because the evidence does not describe the Chinese personal-care brand's products, ownership, or history in detail, this entry should be treated as a preliminary identity record. Further verification against the brand's own corporate materials is required before the dossier can be considered complete.
Controversies
2026
Penalized for failure to disclose related-party transactions and other violations
In July 2026, Breo received a final administrative penalty decision from the Shenzhen Securities Regulatory Bureau over violations including the failure to disclose related-party transactions. The company, its chairman, and other related parties were fined a combined total of more than 10 million yuan.
2026
Actual controller suspected of manipulating company stock, receives proposed penalty and market ban notice
In June 2026, Breo's actual controller Ma Xuejun received a prior notice of proposed penalty. Regulators found that he and several others manipulated the company's stock, and proposed a fine and a five-year market ban. This case is separate from the company's information disclosure case and remains at the proposed penalty stage.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/breo-global · Editorial policy · How profiles are compiled